| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8285519 | Parkinsonism & Related Disorders | 2018 | 5 Pages |
Abstract
Key findings of CSP 468 were reflected in our target selection of DBS for Parkinson's Disease. Following CSP 468, GPi targeting increased, and it was selected for patients with poorer cognitive and mood indices.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Derek G. Southwell, Martin J. Rutkowski, Marta San Luciano, Caroline Racine, Jill Ostrem, Philip A. Starr, Paul S. Larson,